eResearch

Top-Ten Dividend Portfolio Drops 4.2% in Late November Swoon

November 30, 2021 Bob Weir

Finally, our long-expected market pull-back and, typically, in just a few days of trading. The market may attach itself to the current negative sentiment and decline further. However, we are heading into the market’s usual strong performance period. December is usually a good month for the market, and this normally extends into the New Year. But this year could be different. By all means, take advantage of washed out quality companies, but be careful with your buying proclivities. [more]

Food Quarterly – Who Decides What’s For Dinner Tonight?

November 29, 2021 Claude Camire

We review different companies that compose the industry: the trends, issues, challenges, and their strategies. For this first edition, we will just provide an overview of the key points. Our ultimate goal is to identify companies and products that may have a strategic advantage in competing in this transforming industry.
[more]

DCM Q3 Financials In-line as Consolidation Improves Cash Flow

November 24, 2021 Chris Thompson

We have written a 19-page Update Report on DCM. The communications and marketing solutions provider continues its “Digital-First” strategy and leveraging its existing platforms for direct-to-print applications, marketing and workflow management, and DAM solutions. Revenue was $56.9M, up 3.1% from $55.2M in Q2/2021. Adjusted EBITDA was $9.4M and improved cash flow reduced debt in the quarter by $2.8M. We are maintaining a Buy rating and increasing the one-year price target to $3.75/share from $3.60/share. [more]

InvestorIntel Video – Tracy Weslosky Interviews Chris Thompson about eResearch’s Update Report on Xortx

November 18, 2021 Chris Thompson

In this short video, Tracy Weslosky of InvestorIntel interviews Chris Thompson of eResearch about eResearch’s Update Report on Xortx Therapeutics pertaining to the Company’s recent $21 million financing and U.S. listing. [more]

Seasonality Trends for November 2021

November 2, 2021 Bob Weir

The market is entering its historically strong seasonal period, which runs from late October until about mid-May. If this holds true again this/next year, the Indexes will be pounding out new all-time highs on a regular basis. While this could happen, we must also be on the lookout for the “promised” pull-back. [more]

Analyst Articles

XORTX Moving to the Next Phase

November 1, 2021 Chris Thompson

New 25-page Update Equity Research Report on XORTX, with a Buy rating and one-year price target of $26.00/share. The Company has two potential late-stage drugs in development focused on kidney diseases with one drug that could be approved within the next 18 months and the other drug that could have an orphan drug indication on the market in 2025. [more]

Top-10 Dividend Portfolio Rebounds in October, Up 3.0%

October 30, 2021 Bob Weir

October proved to be a good month for our Portfolio, and now we are heading into the market’s strongest period. Our excellent dividend-paying companies and the strong overall market performance combined to send our Portfolio up 8.2% since its inception last June 1. [more]

Chart of the Day – Canadian Utilities Limited

October 25, 2021 Bob Weir

Canadian Utilities has an attractive dividend yield and also some appreciation potential from current levels. [more]

InvestorIntel Video – Tracy Weslosky Interviews Chris Thompson about eResearch’s Update Report on EQ Works

October 12, 2021 Chris Thompson

In this short video, Tracy Weslosky of InvestorIntel interviews Chris Thompson of eResearch about eResearch’s Update Report on EQ Works pertaining to the Company’s recent release of its Q2/2021 financial results that had revenue increases 71% Q/Q and 74% Y/Y. [more]

Chart of the Day – Update to the Suncor Energy Chart

October 11, 2021 Bob Weir

This is an update article to the original “Chart of the Day” report on Suncor from September 20, 2021. Suncor’s stock price is up 19% in 3 weeks. [more]